bioanalytical systems, iNC.
2701 Kent Avenue
West Lafayette, IN 47906
February 25, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas Lamparski
| RE: | Bioanalytical Systems, Inc. |
Registration Statement on Form S-3
Filed February 19, 2021
File No. 333-253309
Request for Acceleration
Ladies and Gentlemen:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Bioanalytical Systems, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to March 1, 2021, at 5:00 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Stephen J. Hackman of Ice Miller LLP, counsel to the Company, at (317) 236-2289, with any comments or questions regarding the Registration Statement.
| Very truly yours, | |
| bioanalytical systems, Inc. | |
| /s/ Robert Leasure, Jr. | |
| Robert Leasure, Jr. | |
| President & Chief Executive Officer |
cc: Stephen J. Hackman, Esq., Ice Miller LLP
